Page last updated: 2024-08-23

mifepristone and Atherogenesis

mifepristone has been researched along with Atherogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inaba, N; Kurachi, H; Mochizuki, Y; Ohmichi, M; Oishi, A; Takahashi, K1
Blaxall, BC; Dhawan, L; Liu, B; Taubman, MB1

Other Studies

2 other study(ies) available for mifepristone and Atherogenesis

ArticleYear
Role of glucocorticoid receptor in the inhibitory effect of medroxyprogesterone acetate on the estrogen-induced endothelial nitric oxide synthase phosphorylation in human umbilical vein endothelial cells.
    Fertility and sterility, 2011, Mar-01, Volume: 95, Issue:3

    Topics: Atherosclerosis; Cells, Cultured; Contraceptive Agents, Female; Endothelial Cells; Estrogens; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Glucocorticoid; Risk Factors; RNA, Small Interfering; Umbilical Veins

2011
A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability.
    The Journal of biological chemistry, 2007, Apr-06, Volume: 282, Issue:14

    Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell-Free System; Cells, Cultured; Chemokine CCL2; Dexamethasone; Hormone Antagonists; Humans; Inflammation; Male; Mifepristone; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA Stability

2007